Core Insights - The Beauty Health Company (SKIN) experienced a total revenue of 78.8millionforthequarterendingSeptember2024,reflectingayear−over−yeardeclineof19.116.1 million, which was a slight miss compared to analyst expectations of 16.16million.Thisrepresentsadeclinefrom19.2 million (21.19%) in the previous quarter and 21.1million(21.6610.8 million, accounting for 13.71% of total revenue, which was significantly below the expected 14.08million,markingadeclinefrom13.6 million (15.01%) in the previous quarter and 24.7million(25.3676.58 million for the current fiscal quarter, indicating a decline of 20.9% from the prior-year quarter. Expected contributions from EMEA and Asia Pacific are 16.2million(21.215.82 million (20.7%), respectively [7] - For the entire year, total revenue is forecasted at 327.38million,areductionof17.768.27 million (20.9%) and Asia Pacific $57.88 million (17.7%) [8] Market Observations - The company's reliance on international markets presents both opportunities and risks, making it essential to monitor international revenue trends for future forecasts [9] - Wall Street analysts are closely observing these international revenue patterns, especially given the complexities of global interdependence and geopolitical issues [10]